Adawi Kamal 4
4 · FATE THERAPEUTICS INC · Filed Oct 21, 2025
Insider Transaction Report
Form 4
Adawi Kamal
Chief Financial Officer
Transactions
- Award
Common Stock
2025-10-20+75,000→ 75,000 total - Award
Stock Option (Right to Buy)
2025-10-20+375,000→ 375,000 totalExercise: $1.54Exp: 2035-10-20→ Common Stock (375,000 underlying)
Footnotes (2)
- [F1]Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of November 1, 2026, November 1, 2027, November 1, 2028, and November 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
- [F2]The option shall vest as to 25% of the underlying shares on October 20, 2026 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date.